GGrantIndex
Sort

34,240 grants matching atherosclerosis

Mapping, modeling, and manipulating 3D contacts in vascular cells to connect risk variants to disease genes

$721,928
Jesse M Engreitz · Stanford University · R01 · FY2022 · HL

Targeting Endothelial Cell Mineralocorticoid Receptor Against Aortic Aneurysm in Females

$721,911
Zhenheng Guo · University Of Kentucky · R01 · FY2024 · HL

Targeting Endothelial Cell Mineralocorticoid Receptor Against Aortic Aneurysm in Females

$721,911
Zhenheng Guo · University Of Kentucky · R01 · FY2025 · HL

Natural History of Vulnerable Coronary Plaques

$721,856
Guillermo J. Tearney · Massachusetts General Hospital · R01 · FY2011 · HL

Advanced Non-invasive Imaging in the Investigation of Aortic Stenosis Pathobiology

$721,793
Jonathan R Lindner · University Of Virginia · R01 · FY2023 · HL

Lipoproteins and PEDF in the Vascular Complications of Diabetes

$721,707
Timothy J Lyons · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2010 · DK

Unexpectedly Profound Role of Water in Biology and Medicine

$721,697
Gerald H Pollack · University Of Washington · R01 · FY2013 · GM

Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)

$721,691
Priscilla Y. Hsue · University Of California Los Angeles · R01 · FY2024 · HL

Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPs

$721,632
Ivona Pandrea · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · HL

Phase resolved ARF optical coherence elastography for intravascular imaging

$721,594
Zhongping Chen · University Of California-Irvine · R01 · FY2016 · HL

Mechanisms of Vascular Dysfunction in Acute Insulin Resistance

$721,577
Joseph A. Vita · Boston University Medical Campus · P50 · FY2007 · HL

Elucidating the Biology of Cardiovascular Risk in Hemodialysis Patients Using Proteomics

$721,496
Ruth Dubin · Ut Southwestern Medical Center · R01 · FY2023 · HL

Carotid plaque characteristics by MRI in AIM-HIGH

$721,445
Xue-Qiao Zhao · University Of Washington · R01 · FY2008 · HL

SIV Pathogenesis in African Green Monkeys and Pigtailed Macaques

$721,435
Ivona Pandrea · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · HL

Progression of Coronary Atherosclerosis in MACS

$721,431
Wendy S Post · Johns Hopkins University · R01 · FY2016 · HL

Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults

$721,316
Morgan Erika Grams · New York University School Of Medicine · R01 · FY2022 · DK

Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)

$721,297
Priscilla Y. Hsue · University Of California, San Francisco · R33 · FY2022 · HL

Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)

$721,297
Priscilla Y. Hsue · University Of California, San Francisco · R33 · FY2020 · HL

Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)

$721,297
Priscilla Y. Hsue · University Of California, San Francisco · R33 · FY2021 · HL

Integrating Artificial Intelligence for Optimal Analysis of CardiacPET/CT

$721,291
Piotr J Slomka · Cedars-Sinai Medical Center · R01 · FY2025 · EB

Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates

$721,178
Ryan Eugene Temel · University Of Kentucky · R01 · FY2017 · HL

Epidemiology of CHD of men aged 40+ in US, Hawaii, Japan

$721,090
Akira Sekikawa · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · HL

Atherogenic Mechanisms of Electronic Nicotine Delivery Systems

$721,087
Sanjay Srivastava · University Of Louisville · R01 · FY2021 · HL

Measuring arterial material properties using wave-based approaches with ultrasound and computational models

$720,989
Matthew William Urban · Mayo Clinic Rochester · R01 · FY2020 · HL

Novel pathways controlling macrophage inflammation and resolution in atherosclerosis

$720,981
Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2022 · HL